Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.
Pigmentary aberrations are well known side effects of cytostatic chemotherapeutic agents. We report an unusual pattern of supravenous hyperpigmentation occurring after CHOP chemotherapy.
Schulte-Huermann
P
P
Department of Dermatology, Heinrich Heine University, Düsseldorf, Germany.
Zumdick
M
M
Ruzicka
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002081:Buttocks; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005542:Forearm / Q000098:blood supply*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D014680:Veins; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone